Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Psyched Wellness Ltd. (PSYC) is one of 17 companies in the United States and Canada that will be included in the first psychedelic exchange-traded fund
  • The fund will be managed by Horizons ETF Management
  • The Horizons Psychedelic Stock Index ETF index is expected to start trading today, under the ticker PSYK on the NEO Exchange
  • Psyched CEO Jeff Stevens said the company is pleased to be included in the first psychedelics ETF
  • Psyched Wellness Ltd. is up 13.58 per cent to C$0.46 per share

Psyched Wellness Ltd. (PSYC) is one of 17 companies in the United States and Canada that will be included in the first psychedelic exchange-traded fund.

The fund will be managed by Horizons ETF Management.

The Horizons Psychedelic Stock Index ETF index is expected to start trading today, under the ticker PSYK on the NEO Exchange.

Psyched CEO Jeff Stevens said the company is pleased to be included in the first psychedelics ETF.

“We are the only publicly traded company working with a legal psychoactive mushroom and we are advancing novel muscimol-based therapeutics using our proprietary extract, AME-1,” Stevens said.

Psyched Wellness is a Canadian-based life sciences company focused on the production and distribution of artisanal, functional and psychedelic mushrooms.

The company is in the process of developing a line of Amanita muscaria-derived water-based extracts, teas and capsules designed to help with three health objectives: promote stress relief, relaxation and assist with restful sleeping.

Psyched Wellness Ltd. is up 13.58 per cent to C$0.46 per share at 11:48 am EST.

More From The Market Herald

" Optimi Health (CSE:OPTI) acquires catalog of psychedelic and functional mushroom genetics

Optimi Health (OPTI) has acquired a catalog of psilocybin and functional mushroom strains.

" Nirvana Life Sciences Inc (CSE:NIRV) signs LOI with Innovate Phytotechnologies Inc

Nirvana Life Sciences (NIRV) has  signed a letter of intent with Innovate Phytotechnologies Inc. (INVP)
Clearmind Medicine - CEO, Adi Zuloff Shani.

" Clearmind Medicine (CSE:CMND) announces upcoming pre-IND meeting with the FDA

Clearmind (CMND) will participate in a pre-IND meeting with the FDA on May 18, 2022.
Red Light Holland - Advisor, Akwasi Owusu Bempah.

" Red Light Holland (CSE:TRIP) adds Akwasi Owusu-Bempah to Advisory Board

Red Light Holland (TRIP) has hired drug law expert Akwasi Owusu-Bempah as its newest advisor.